Detalles de la búsqueda
1.
Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies.
Mol Psychiatry
; 25(7): 1580-1591, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30374191
2.
Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study.
Mult Scler
; 26(13): 1729-1739, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31680631
3.
Transition of Patients with Opioid Use Disorder from Buprenorphine to Extended-Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition Regimens.
Am J Addict
; 29(4): 313-322, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32246728
4.
Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation-Associated Thrombotic Microangiopathy.
J Clin Oncol
; 40(22): 2447-2457, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35439028
5.
Cognitive performance of patients with opioid use disorder transitioned to extended-release injectable naltrexone from buprenorphine: Post hoc analysis of exploratory results of a phase 3 randomized controlled trial.
Addict Behav
; 111: 106538, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32777606
6.
Combination of olanzapine and samidorphan has no clinically relevant effects on ECG parameters, including the QTc interval: Results from a phase 1 QT/QTc study.
Prog Neuropsychopharmacol Biol Psychiatry
; 100: 109881, 2020 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32004636
7.
Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism.
Addiction
; 115(2): 239-246, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31313402
8.
Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial.
J Clin Pharmacol
; 59(2): 206-217, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30102427
9.
Abuse Potential of Samidorphan: A Phase I, Oxycodone-, Pentazocine-, Naltrexone-, and Placebo-Controlled Study.
J Clin Pharmacol
; 59(2): 218-228, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30476361
10.
Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial.
Drug Alcohol Depend
; 187: 171-178, 2018 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29674251
11.
Optimizing adaptive design for Phase 2 dose-finding trials incorporating long-term success and financial considerations: A case study for neuropathic pain.
Contemp Clin Trials
; 57: 69-86, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28385653
12.
Reply to Kunoe (2020) and Ghosh & Singh (2020) regarding Nunes et al. (2020): Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism.
Addiction
; 115(11): 2188-2190, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32533597
13.
Effects of valdecoxib in the treatment of chronic low back pain: results of a randomized, placebo-controlled trial.
Clin Ther
; 26(8): 1249-60, 2004 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15476906
Resultados
1 -
13
de 13
1
Próxima >
>>